Impact of COVID-19 on metabolic parameters in patients with type 2 diabetes mellitus

BMC Pulmonary Medicine

Table 2 Clinical and laboratory data of patients in ‘COVID-19 negative’ group

Values	Before the pandemic	Six months after the pandemic	P-Value
Weight ^a (kg)	76.3 ± 10.2	75.8 ± 10.1	0.168
BMI ^a (kg/m2)	27 ± 3.6	26.8 ± 3.5	0.168
Systolic BP (mmHg)	130 ± 25	130 ± 20	0.805
Diastolic BP (mmHg)	70 ± 15	70 ± 15	0.469
MAP ^a (mmHg)	93.2 ± 9.2	92.5 ± 10.2	0.896
FPG ^a (mg/dL)	145.4 ± 40	141.7 ± 41.8	0.614
HbA1C ^a (%)	7.2 ± 1.1	7.3 ± 1.3	0.589
Urea (mg/dL)	30.9 ± 15.2	27.5 ± 12	0.714
Cr (mg/dL)	0.91 ± 0.23	0.9 ± 0.2	0.472
eGFR (mL/min/1.7/m2)	74.4 ± 18.6 ^a	73.6 ± 23.7	0.461
TG (mg/dL)	139 ± 72	147.5 ± 62.8 ^a	0.865
TC (mg/dL)	150 ± 65	145.6 ± 32.9	0.001
LDL-C (mg/dL)	74 ± 38	71.3 ± 24.4 ^a	0.01
HDL-C (mg/dL)	48 ± 14	49 ± 12 ^a	0.689
AIP	0.45 ± 0.21	0.44 ± 0.24 ^a	0.43
TyG index	3.98 ± 0.29	3.95 ± 0.24 ^a	0.87
TyG-BMI index	107.44 ± 19.12 ^a	105.82 ± 29.68	0.89

Note: Values were presented as median ± Interquartile Range or number. ^a Values with normal distribution were presented as mean ± Standard deviation. Abbreviations: COVID-19, coronavirus disease 2019; BMI, body mass index; BP, blood pressure; MAP, mean arterial pressure; FPG, fasting plasma glucose; HbA1c, glycated hemoglobin; Cr, creatinine; eGFR, estimated glomerular filtration rate; TG, triglyceride; TC, total cholesterol; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; AIP, atherogenic index of plasma; TyG index, triglyceride–glucose index; TyG-BMI, triglyceride-glucose body mass index

ISSN: 1471-2466